Carnosine: Molecular Structure

Molecular Structure#

Carnosine (beta-alanyl-L-histidine) is one of the simplest naturally occurring peptides, consisting of just two amino acid residues joined by a single peptide bond. Despite this structural simplicity, carnosine's chemistry gives rise to a remarkably diverse set of biological activities.

Primary Structure#

Carnosine is formed by a peptide bond between the carboxyl group of beta-alanine and the alpha-amino group of L-histidine. Notably, beta-alanine is a non-proteinogenic amino acid (it has its amino group on the beta carbon rather than the alpha carbon), which means carnosine cannot be incorporated into proteins during translation. This unique structure allows carnosine to accumulate at millimolar concentrations in tissues without interfering with protein synthesis.

Functional Groups#

The carnosine molecule contains several chemically active functional groups:

• Imidazole ring (from histidine): Responsible for pH buffering (pKa 6.83), metal chelation, and antioxidant activity
• Free amino group (from beta-alanine): Participates in scavenging reactive carbonyl species
• Carboxyl group (from histidine): Contributes to metal chelation and water solubility
• Peptide bond: Subject to hydrolysis by carnosinase enzymes

Chemical Properties#

pH Buffering#

The most physiologically significant property of carnosine is the pKa of its imidazole ring at 6.83. This value falls within the physiological pH range of exercising muscle (pH 6.5-7.1), making carnosine an effective intracellular buffer. In skeletal muscle, carnosine accounts for approximately 10-20% of total buffering capacity.

The buffering pKa of 6.83 represents an increase from free histidine's imidazole pKa of approximately 6.1. The peptide bond with beta-alanine shifts the pKa upward, placing it more optimally in the buffering range relevant to metabolic acidosis during high-intensity exercise.

Solubility and Stability#

Carnosine is highly water-soluble and stable as a dry powder. In aqueous solution, it is susceptible to hydrolysis by carnosinase enzymes but is relatively stable under physiological conditions in the absence of these enzymes. The compound is heat-stable and resistant to acid hydrolysis at moderate temperatures.

Related Histidine-Containing Dipeptides#

Carnosine belongs to a family of histidine-containing dipeptides (HCDs):

Enzymatic Metabolism#

Synthesis#

Carnosine is synthesized by carnosine synthase (also called beta-alanine-histidine N-methyltransferase, CARNS1), an ATP-dependent enzyme that catalyzes the peptide bond formation between beta-alanine and L-histidine. Beta-alanine availability is the rate-limiting factor for carnosine synthesis, which is why beta-alanine supplementation effectively increases muscle carnosine levels.

Degradation#

Two carnosinase enzymes degrade carnosine:

• Serum carnosinase (CN1/CNDP1): Secreted into the bloodstream, this enzyme rapidly hydrolyzes circulating carnosine. Humans have uniquely high CN1 activity compared to other mammals, which significantly limits the bioavailability of orally administered carnosine.
• Tissue carnosinase (CN2/CNDP2): A cytoplasmic non-specific dipeptidase with broader substrate specificity and lower activity toward carnosine.

The high serum carnosinase activity in humans represents a major pharmacological challenge. Genetic polymorphisms in the CNDP1 gene (particularly the CTG repeat polymorphism encoding different numbers of leucine residues in the signal peptide) affect CN1 activity and are associated with variation in carnosine metabolism and susceptibility to diabetic nephropathy.

Pharmacokinetic Considerations#

Oral carnosine is absorbed intact through intestinal peptide transporters (PepT1), but is then rapidly hydrolyzed by serum CN1 in the bloodstream. The plasma half-life of intact carnosine is on the order of minutes. However, the constituent amino acids (beta-alanine and histidine) are taken up by tissues and used to resynthesize carnosine intracellularly.

Strategies to overcome the carnosinase barrier include:

• N-acetylcarnosine: Used in eye drops; the acetyl group provides protection from CN1 hydrolysis
• Beta-alanine supplementation: Bypasses the bioavailability issue entirely by supplying the rate-limiting precursor
• Carnosinase-resistant analogs: Synthetic derivatives such as carnosine amide and D-carnosine that resist CN1 hydrolysis are under investigation

Related Reading#

• Carnosine overview and research guide
• Peptides similar to Carnosine
• Carnosine research evidence